NASDAQ$DCGO
Docgo Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
DocGo's Q1 2022 earnings showcased strong growth, with revenue significantly increasing and the company progressing in its transition to non-COVID related services.
DocGo reported a strong first quarter in 2022, with revenue increasing by 137% compared to the previous year. The company is transitioning from COVID-related services to longer-term, non-COVID work and expanding its geographic reach. They generated strong net income and cash flow, and expect to see continued improvements in profitability over time.
- Revenue increased by 137% compared to the year-ago period.
- The company is transitioning from Covid-related services to longer term non-Covid related work.
- DocGo is expanding its breadth and geographic reach, adding new services in new states.
- The company generated strong net income and cash flow.
Headline financials
Revenue & EPS history
Docgo · Revenue · Quarterly
$118M
Revenue by segment
Docgo · $187M total across 2 segments · Q3 2023
- Mobile Health Services$139M—74.7%
- Transportation Services$47.2M—25.3%
Forward guidance
The company is reiterating its prior revenue guidance for fiscal year 2022 of approximately $400-420 million and Adjusted EBITDA is anticipated to be approximately $35-41 million for 2022.
Tailwinds
- Strong demand from its customers for both mobile health and transportation services.
- Revenue guidance for fiscal year 2022 of approximately $400-420 million.
- Represents growth of 25-32% over 2021 revenues.
- Excluding estimated Covid testing revenues from both years, its 2022 revenue guidance would represent an annual increase of 65% - 75% over 2021.
- Adjusted EBITDA is anticipated to be approximately $35-41 million for 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2022
+1.9%
Avg return
Earnings day
+2.0%
Avg return
5 days after
-1.6%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+32.3%
Q2 2021
Best reaction
-40.4%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.3% | +0.2% | -2.6% | |
| Q4 2025 | +17.7% | +4.0% | -9.7% | |
| Q3 2025 | +0.0% | -3.6% | -15.3% | |
| Q1 2025 | -40.4% | -39.9% | -34.3% | |
| Q4 2024 | -21.2% | -22.4% | -32.7% | |
| Q3 2024 | +9.6% | +14.0% | +11.8% | |
| Q2 2024 | +18.2% | +7.8% | +18.2% | |
| Q1 2024 | -13.5% | -11.2% | -12.6% | |
| Q4 2023 | +4.1% | +0.3% | +3.3% | |
| Q3 2023 | +1.2% | -5.3% | -9.3% | |
| Q2 2023 | +13.9% | +12.1% | -15.6% | |
| Q1 2023 | +5.2% | +2.4% | +11.3% | |
| Q4 2022 | -1.5% | -4.9% | -4.7% | |
| Q3 2022 | -7.7% | -5.1% | -19.8% | |
| Q2 2022 | +4.1% | +16.9% | +11.5% | |
| Q1 2022 | -0.8% | -7.3% | +16.7% | |
| Q2 2021 | +32.3% | +48.9% | +36.2% | |
| Q4 2021 | +13.2% | +39.2% | +29.7% | |
| Q3 2021 | +4.0% | -2.2% | -15.9% | |
| Q1 2021 | -0.4% | -0.4% | -0.1% | |
| Q4 2020 | -0.8% | -0.5% | +0.3% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro